Therapure Biopharma Inc develops, manufactures, fills and packages complex high-quality biological therapeutics.

Taking products from the lab to the market, Therapure Biopharma offers clients scientific, manufacturing and downstream purification services. With over 30, 000 square feet of cGMP manufacturing space in the 130,000 square feet facility, Therapure's therapeutic protein expertise positions them as the ideal company to assist with the manufacture, regulation, commercialization and approval of these products.

Covering all aspects of therapeutic protein production, Therapure Biopharma combines its knowledge of advanced biology, complex proteins and regulatory processes with its disciplined quality focused approach to meet client's protein manufacturing requirements.
Therapure's biomanufacturing capabilities include protein purification, cell culture, formulation, fill, lyophilization and finishing and with over 20 years of experience. The highly qualified team at Therapure ensure that all products meet quality, safety and efficacy requirements. The company also supplies services that include process and test development, final release testing, packaging and shipping.

In addition to the services on offer, Therapure is also developing a proprietary pipeline of products. Current therapeutics in the pipeline includes:

• TBI 301 - a conjugate of haemoglobin and ribavarin indicated for HCV infections, that targets the liver.
• TBI 302 - Delivering the chemotherapeutic agent floxuridine with haemoglobin to the liver in patients with hepatocellular carcinoma and metastatic colorectal cancer.
• TBI 303 - Indicated for a variety of disease areas TBI 303 is a protein modification technology which increases the half life of protein based therapeutics
• TBI 304 - Indicated for chemotherapy-induced anemia, monoclonal antibody TBI 304 stimulates the production of red blood cells.

At the later stage of development Therapure has an excellent knowledge of the licensing of therapeutic proteins and can enable the many business opportunities available in the evolving protein market.

Offering a full range of protein production services Therapure can partner with you to address your manufacturing, regulatory and licensing challenges of your therapeutic proteins.

Therapure is also seeking partners to further develop its novel pipeline of proprietary products and technologies.